α-TEA cooperates with MEK or mTOR inhibitors to induce apoptosis via targeting IRS/PI3K pathways

被引：0
|
作者：
R Tiwary
W Yu
B G Sanders
K Kline
机构：
[1] School of Biological Sciences/C0900,Department of Nutritional Sciences/A2703
[2] University of Texas,undefined
[3] 1 University Station,undefined
[4] University of Texas,undefined
[5] 1 University Station,undefined
来源：
British Journal of Cancer | 2011年 / 104卷
关键词：
-TEA; Akt; breast cancer; ERK; IRS-1; mTOR;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：101 / 109
页数：8
相关论文
共 50 条
  • [31] Activation of PI3K/Akt/mTOR Pathway and Dual Inhibitors of PI3K and mTOR in Endometrial Cancer
    Chen, Jiezhong
    Zhao, Kong-Nan
    Li, Rui
    Shao, Renfu
    Chen, Chen
    CURRENT MEDICINAL CHEMISTRY, 2014, 21 (26) : 3070 - 3080
  • [32] THE ROLE OF CDK AND PI3K/MTOR INHIBITORS
    Andre, Fabrice
    BREAST, 2015, 24 : S25 - S25
  • [33] Prospects for personalized medicine with inhibitors targeting the RAS and PI3K pathways
    Lackner, Mark R.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2010, 10 (01) : 75 - 87
  • [34] Combined targeting of MEK and PI3K/mTOR effector pathways is necessary to effectively inhibit NRAS mutant melanoma in vitro and in vivo
    Posch, Christian
    Moslehi, Homayoun
    Feeney, Luzviminda
    Green, Gary A.
    Ebaee, Anoosheh
    Feichtenschlager, Valentin
    Chong, Kim
    Peng, Lily
    Dimon, Michelle T.
    Phillips, Thomas
    Daud, Adil I.
    McCalmont, Timothy H.
    LeBoit, Philip E.
    Ortiz-Urda, Susana
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2013, 110 (10) : 4015 - 4020
  • [35] Dual Targeting of MEK and PI3K Pathways Attenuates Established and Progressive Pulmonary Fibrosis
    Madala, Satish K.
    Edukulla, Ramakrishna
    Phatak, Mukta
    Schmidt, Stephanie
    Davidson, Cynthia
    Acciani, Thomas H.
    Korfhagen, Thomas R.
    Medvedovic, Mario
    LeCras, Timothy D.
    Wagner, Kimberly
    Hardie, William D.
    PLOS ONE, 2014, 9 (01):
  • [36] Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Inhibitors: Rationale and Importance to Inhibiting These Pathways in Human Health
    Chappell, William H.
    Steelman, Linda S.
    Long, Jacquelyn M.
    Kempf, Ruth C.
    Abrams, Stephen L.
    Franklin, Richard A.
    Baesecke, Joerg
    Stivala, Franca
    Donia, Marco
    Fagone, Paolo
    Malaponte, Graziella
    Mazzarino, Maria C.
    Nicoletti, Ferdinando
    Libra, Massimo
    Maksimovic-Ivanic, Danijela
    Mijatovic, Sanja
    Montalto, Giuseppe
    Cervello, Melchiorre
    Laidler, Piotr
    Milella, Michele
    Tafuri, Agostino
    Bonati, Antonio
    Evangelisti, Camilla
    Cocco, Lucio
    Martelli, Alberto M.
    McCubrey, James A.
    ONCOTARGET, 2011, 2 (03) : 135 - 164
  • [37] PI3K/Akt/mTOR and Ras/Raf/MEK/ERK signaling pathways inhibitors as anticancer agents: Structural and pharmacological perspectives
    Asati, Vivek
    Mahapatra, Debarshi Kar
    Bharti, Sanjay Kumar
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2016, 109 : 314 - 341
  • [38] EGCG and ECG induce apoptosis and decrease autophagy via the AMPK/mTOR and PI3K/AKT/mTOR pathway in human melanoma cells
    DU Bing-Xin
    LIN Pei
    LIN Jun
    Chinese Journal of Natural Medicines, 2022, 20 (04) : 290 - 300
  • [39] EGCG and ECG induce apoptosis and decrease autophagy via the AMPK/mTOR and PI3K/AKT/mTOR pathway in human melanoma cells
    Du Bing-Xin
    Lin Pei
    Lin Jun
    CHINESE JOURNAL OF NATURAL MEDICINES, 2022, 20 (04) : 290 - 300
  • [40] Apatinib induces apoptosis and autophagy via the PI3K/AKT/mTOR and MAPK/ERK signaling pathways in neuroblastoma
    Yu, Xiying
    Fan, Hongjun
    Jiang, Xingran
    Zheng, Wei
    Yang, Yanan
    Jin, Mei
    Ma, Xiaoli
    Jiang, Wei
    ONCOLOGY LETTERS, 2020, 20 (04)
12345